The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis

被引:40
|
作者
Gao, Fei [1 ]
Zhou, Bin [2 ]
Xu, Jun-Chi [3 ]
Gao, Xin [1 ]
Li, Shu-Xiang [1 ]
Zhu, Geng-Chao [1 ]
Zhang, Xue Guang [2 ]
Yang, Chen [1 ]
机构
[1] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou 215000, Jiangsu, Peoples R China
[2] Soochow Univ, Inst Clin Immunol Jiangsu Prov, Suzhou 215007, Peoples R China
[3] Fifth Peoples Hosp Suzhou, Suzhou, Jiangsu, Peoples R China
关键词
LGR5; ALDH1A1; NSCLC; Clinical pathology; Prognosis; STEM-CELLS; EXPRESSION; IDENTIFICATION; PROMISE; MARKER; COLON;
D O I
10.1016/j.bbrc.2015.04.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Leucine rich repeat containing G protein coupled receptor 5 (LGR5), may be a candidate marker of non-small cell lung cancer (NSCLC) cells with stem cell-like properties. Aldehyde dehydrogenase 1A1 (ALDH1A1) is one of NSCLC stem cell markers. To identify the relationship of LGR5 and ALDH1A1 in NSCLC, we analyzed the expression of LGR5 and ALDH1A1 in NSCLC samples, and determined their clinical significance. We performed quantitative RT-PCR for LGR5 and ALDH1A1 expression in 24 NSCLC patients, and showed that LGR5 and ALDH1A1 mRNA were frequently increased in NSCLC tissues in comparison to that in adjacent normal tissues (p = 0.0005 and p < 0.0001, respectively). Besides, the expression of LGR5 and ALDH1A1 mRNA has a significant correlation (r = 0.416, P = 0.0483). The expression of LGR5 and ALDH1A1 in 109 NSCLC tumors and 50 adjacent normal tissues were detected by immunohistochemistry. Positive LGR5 and ALDH1A1 expression was defined in 28.4% and 41.3% of the NSCLC tumors, respectively. Further analysis indicated that 24 of these LGR5(+) (24/31) samples expressed ALDH1A1(r = 0.3883, p < 0.0001), we also found co-localization of LGR5 and ALDH1A1 in tumor tissue samples. LGR5 and ALDH1A1 expression was significantly associated with higher pathological TNM stage of the disease (stage I + II and III + IV) (P = 0.0311 and p = 0.0221, respectively), the co-expression of LGR5 and ALDH1A1 was associated with nodal status (p = 0.0424). High expression of LGR5 or ALDH1A1 was related to poor prognosis (P = 0.0125 and p = 0.0410, respectively), and NSCLC patients with co-expression of LGR5 and ALDH1A1 had a poorer prognosis than the others (P = 0.0011). Both of them can be an independent risk factor of a poorer prognosis (P = 0.016 and P = 0.024, respectively). The expression of LGR5 and ALDH1A1 were closely associated with the tumorigenicity, metastasis and poor prognosis of NSCLC, and LGR5+ cells in NSCLC were likely to be the cancer cells with stem cell-like properties due to the significant correlation between LGR5 and ALDH1A1. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 50 条
  • [1] The biological functions of LGR5 in promoting non-small cell lung cancer progression
    Gao, Fei
    Xu, Jun-Chi
    You, Xin-Ran
    Gao, Xin
    Wei, Jia-Ling
    Li, Shu-Xiang
    Zhu, Chen-Lu
    Yang, Chen
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (01) : 203 - 211
  • [2] Serum ALDH1A1 is a tumor marker for the diagnosis of non-small cell lung cancer
    Cao, Yong-Tong
    Li, Jing-Hua
    Wang, Yuan-Tao
    Fu, Yao-Wen
    Xu, Jing
    TUMORI JOURNAL, 2014, 100 (02): : 214 - 218
  • [3] ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer
    Xiao-shan Li
    Qing Xu
    Xiang-yang Fu
    Wei-sheng Luo
    BMC Cancer, 14
  • [4] ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer
    Li, Xiao-shan
    Xu, Qing
    Fu, Xiang-yang
    Luo, Wei-sheng
    BMC CANCER, 2014, 14
  • [5] Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells
    Liu, Xinwei
    Wang, Lihui
    Cui, Wei
    Yuan, Xiangzhong
    Lin, Lulu
    Cao, Qi
    Wang, Nannan
    Li, Yi
    Guo, Wei
    Zhang, Xun
    Wu, Chunfu
    Yang, Jingyu
    ONCOTARGET, 2016, 7 (36) : 58516 - 58530
  • [6] Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer
    Raz, Guy
    Allen, Kristi E.
    Kingsley, Chris
    Cherni, Irene
    Arora, Shilpi
    Watanabe, Aprill
    Lorenzo, Carlos D.
    Edwards, David K.
    Sridhar, Shravan
    Hostetter, Galen
    Weiss, Glen J.
    LUNG CANCER, 2012, 76 (02) : 191 - 196
  • [7] Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer
    Chen, Xinming
    Shao, Weiwei
    Huang, Hua
    Feng, Xiaochun
    Yao, Sumei
    Ke, Honggang
    HUMAN PATHOLOGY, 2019, 83 : 140 - 148
  • [8] Downregulation of ALDH1A1 expression in non-small cell lung carcinomas - its clinicopathologic and biological significance
    Okudela, Koji
    Woo, Tetsukan
    Mitsui, Hideaki
    Suzuki, Takeshisa
    Tajiri, Michihiko
    Sakuma, Yuji
    Miyagi, Yohei
    Tateishi, Yoko
    Umeda, Shigeaki
    Masuda, Munetaka
    Ohashi, Kenichi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (01): : 1 - 12
  • [9] The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
    Alamgeer, Muhammad
    Ganju, Vinod
    Szczepny, Anette
    Russell, Prudence A.
    Prodanovic, Zdenka
    Kumar, Beena
    Wainer, Zoe
    Brown, Tracey
    Schneider-Kolsky, Michal
    Conron, Matthew
    Wright, Gavin
    Watkins, D. Neil
    THORAX, 2013, 68 (12) : 1095 - 1104
  • [10] Lgr5 in cancer biology: functional identification of Lgr5 in cancer progression and potential opportunities for novel therapy
    Xu, Liangliang
    Lin, Weiping
    Wen, Longping
    Li, Gang
    STEM CELL RESEARCH & THERAPY, 2019, 10 (1)